BigBearai Holdings Inc
For the period ended Mar 31, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 2, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements (Unaudited)
Note 1—Description of the Business
BigBear.ai Holdings, Inc.’s (“BigBear.ai”, “BigBear.ai Holdings”, “BigBear” or the “Company”) mission is to help deliver clarity for the world’s most complex decisions. BigBear.ai is a leading provider of Edge AI-powered decision intelligence solutions for national security, supply chain management and digital identity. Customers and partners rely on BigBear.ai’s predictive analytics capabilities in highly complex, distributed, mission-based operating environments. We are a technology-led solutions organization, providing both software and services to our customers. Unless otherwise indicated, references to “we”, “us” and “our” refer collectively to BigBear.ai Holdings, Inc. and its consolidated subsidiaries.
Note 2—Summary of Significant Accounting Policies
Basis of Presentation
We prepared these accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information, the instructions to Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, they do not include all information and notes required by GAAP for complete financial statements. Amounts presented within the consolidated financial statements and accompanying notes are presented in thousands of U.S. dollars unless stated otherwise, except for percentages, units, shares, per unit and per share amounts.
In the opinion of management, these consolidated financial statements reflect all adjustments that are of a normal recurring nature necessary for a fair presentation of our results of operations, financial condition and cash flows for the interim periods presented. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base these estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Our actual results may differ materially from these estimates. Significant estimates inherent in the preparation of our consolidated financial statements include, but are not limited to, accounting for revenue and cost recognition; evaluation of goodwill; intangible assets; and other assets for impairment; income taxes; equity-based compensation; fair value measurements; and contingencies. We eliminate intercompany balances and transactions in consolidation.
The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the full year or future periods. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024.
Emerging Growth Company
Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the“JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Recent Accounting Pronouncements
Recent Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-09, Improvements to Income Tax
Disclosures (“ASU 2023-09”). Under ASU 2023-09, public benefit entities must disclose specific categories and provide additional information in the tax rate reconciliation if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate. The amendments from ASU 2023-09 are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company will adopt this ASU in 2025 and does not expect this guidance to have a material impact to its consolidated financial statements or related disclosures.
Note 3—Restatement of Previously Issued Financial Statements
As previously disclosed in Note 2 to the Company’s consolidated financial statements as of and for the year ended December 31, 2024, management identified a material error in the previously reported financial statements related to its convertible notes issued in December 2021 and due in December 2026 (“2026 Notes”). The conversion option embedded within the 2026 Notes was incorrectly deemed to be eligible for a scope exception from the bifurcation requirements of ASC 815-15 and therefore required bifurcation as a derivative (“2026 Notes Conversion Option”). The 2026 Notes include certain adjustments to the conversion rate that violate the “fixed-for-fixed” criteria described in Accounting Standards Codification (“ASC”) 815-40. As a result, the prior period consolidated financial statements have been restated to reflect the issuance of the 2026 Notes Conversion Option at fair value as of December 7, 2021 and the subsequent remeasurement to fair value at each reporting date. Changes in the fair value of the 2026 Notes Conversion Option are recorded in the consolidated statements of operations. Bifurcation of the 2026 Notes Conversion Option from its host results in a discount to the 2026 Notes par value. The amortization of the discount to the par of the 2026 Notes is recorded in the consolidated statements of operations as non-cash interest expense using the effective interest rate method.
The effect of the correction noted above on the Company’s consolidated statement of operations for the quarter ended March 31, 2024 was as follows:
| Unaudited consolidated statements of operations | As reported | Adjustment | Restated |
|---|---|---|---|
| Revenues | $33,121 | $— | $33,121 |
| Cost of revenues | 26,135 | — | 26,135 |
| Gross margin | 6,986 | — | 6,986 |
| Operating expenses: | |||
| Selling, general and administrative | 16,948 | — | 16,948 |
| Research and development | 1,144 | — | 1,144 |
| Restructuring charges | 860 | — | 860 |
| Transaction expenses | 1,103 | — | 1,103 |
| Goodwill impairment | 85,000 | — | 85,000 |
| Operating loss | (98,069) | — | (98,069) |
| Net increase in fair value of derivatives | 23,992 | (185) | 23,807 |
| Interest expense | 3,555 | 2,830 | 6,385 |
| Other income | (455) | — | (455) |
| Loss before taxes: | (125,161) | (2,645) | (127,806) |
| Income tax benefit | (14) | — | (14) |
| Net loss | $(125,147) | $(2,645) | $(127,792) |
The effect of the correction noted above on the Company’s consolidated statement of cash flows for the quarter ended March 31, 2024 was as follows:
| Unaudited consolidated statement of cash flows | As reported | Adjustment | Restated |
|---|---|---|---|
| Net loss | $(125,147) | $(2,645) | $(127,792) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization expense | 2,439 | — | 2,439 |
| Amortization of debt issuance costs and discount | 506 | 2,830 | 3,336 |
| Equity-based compensation expense | 5,157 | — | 5,157 |
| Goodwill impairment | 85,000 | — | 85,000 |
| Impairment of right-of-use assets | — | — | — |
| Non-cash lease expense | 94 | — | 94 |
| Provision for doubtful accounts | 171 | — | 171 |
| Deferred income tax benefit | (23) | — | (23) |
| Net increase in fair value of derivatives | 23,992 | (185) | 23,807 |
| Changes in assets and liabilities: | |||
| Increase in accounts receivable | (8,957) | — | (8,957) |
| Decrease in contract assets | 2,443 | — | 2,443 |
| Decrease in prepaid expenses and other assets | 950 | — | 950 |
| Decrease in accounts payable | (5,960) | — | (5,960) |
| Increase in accrued liabilities | 2,599 | — | 2,599 |
| Increase in contract liabilities | 1,826 | — | 1,826 |
| Increase (decrease) in derivative liabilities | — | — | — |
| Increase in other liabilities | 551 | — | 551 |
| Net cash used in operating activities | (14,359) | — | (14,359) |
| Cash flows from investing activities: | |||
| Acquisition of businesses, net of cash acquired | 13,935 | — | 13,935 |
| Purchases of property and equipment | (38) | — | (38) |
| Capitalized software development costs | (1,643) | — | (1,643) |
| Net cash provided by investing activities | 12,254 | — | 12,254 |
| Cash flows from financing activities: | |||
| Proceeds from issuance of shares for exercised RDO and PIPE warrants | 53,809 | — | 53,809 |
| Repayment of short-term borrowings | (403) | — | (403) |
| Proceeds from exercise of options | 86 | — | 86 |
| Payments of tax withholding from the issuance of common stock | (2,532) | — | (2,532) |
| Net cash provided by financing activities | 50,960 | — | 50,960 |
| Net increase in cash and cash equivalents | 48,855 | — | 48,855 |
| Cash and cash equivalents at beginning of year | 32,557 | — | 32,557 |
| Cash and cash equivalents at end of year | $81,412 | $— | $81,412 |
Note 4—Restructuring Charges
During the three months ended March 31, 2025, the Company refined its organizational structure resulting in employee separation costs of $1.7 million, net of tax benefits. The Company had completed this organizational restructuring as of March 31, 2025. There was $1.1 million unpaid employee separation costs related to this organizational restructuring as of March 31, 2025.
During the three months ended March 31, 2024, the Company refined its organization structure resulting in employee separation costs of $0.9 million, net of tax benefits. The Company had completed this restructuring action as of March 31, 2024. There was $0.5 million unpaid employee separation costs related to this restructuring action as of March 31, 2024.
The table below presents the activity in accrued restructuring charges for the three months ended March 31, 2025:
| Total | |
|---|---|
| As of December 31, 2024 | $— |
| Additions | 1,698 |
| Settlements | (593) |
| As of March 31, 2025 | $1,105 |
Note 5—Business Combinations
Pangiam Acquisition
On February 29, 2024, pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated November 4, 2023, by and among BigBear.ai, Pangiam Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company (“Merger Sub”), Pangiam Purchaser, LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of the Company (“Pangiam Purchaser”), Pangiam Ultimate Holdings, LLC, a Delaware limited liability company (the “Seller”), and Pangiam Intermediate Holdings, LLC, a Delaware limited liability company (“Pangiam Intermediate”), (i) Merger Sub merged with and into Pangiam Intermediate, with Merger Sub ceasing to exist and Pangiam Intermediate surviving as a wholly-owned subsidiary of the Company (the “First Merger”), and (ii) immediately following the First Merger, Pangiam Intermediate merged with and into Pangiam Purchaser, with Pangiam Intermediate ceasing to exist and Pangiam Purchaser continuing as a wholly-owned subsidiary of the Company (the “Second Merger”, together with the First Merger, the “Mergers”).
As consideration for the Mergers and the related transactions contemplated by the Merger Agreement, BigBear.ai issued a total of 61,838,072 shares of the Company’s common stock to Seller based on the 20-day volume-weighted average price for common stock ending on the trading day immediately prior to the date of the Merger Agreement of $1.3439, representing an enterprise value of $70 million (which was subject to customary adjustments for indebtedness, cash, working capital and transaction expenses) (the “Purchase Price”), less $3.5 million that was held back from the Purchase Price at the time of the closing of the Mergers to cover any post-closing downward adjustments to the Purchase Price (the “Holdback Amount”). On July 2, 2024 (the “Finalization Date”), BigBear.ai issued 2,144,073 shares of common stock at $1.3905 per share (as determined according to the volume weighted average price over the 20 trading days ending immediately prior to the Finalization Date) as settlement of the final determination of the post-close adjusted Purchase Price.
The following table summarizes the final fair value of the consideration transferred and the fair values of the major classes of assets acquired and liabilities assumed as of the acquisition date.
| February 29, 2024, as reported at March 31, 2024 | Measurement period adjustments | February 29, 2024, as reported at December 31, 2024 | |
|---|---|---|---|
| Holdback amount | $3,500 | $(513) | $2,987 |
| Equity issued | 207,776 | (6) | 207,770 |
| Purchase consideration | $211,276 | $(519) | $210,757 |
| Assets: | |||
| Cash | $13,935 | $— | $13,935 |
| Accounts receivable | 5,848 | (369) | 5,479 |
| Prepaid expenses and other current assets | 143 | 150 | 293 |
| Property and equipment | 635 | — | 635 |
| Right-of-use assets | 5,754 | 188 | 5,942 |
| Intangible assets | 39,100 | (1,035) | 38,065 |
| Other non-current assets | 1,772 | — | 1,772 |
| Total assets acquired | $67,187 | $(1,066) | $66,121 |
| Liabilities: | |||
| Accounts payable | 1,137 | — | 1,137 |
| Accrued expenses | 2,454 | 36 | 2,490 |
| Other current liabilities | 69 | (24) | 45 |
| Deferred revenue | 1,148 | — | 1,148 |
| Current portion of long-term lease liability | 1,080 | (874) | 206 |
| Long-term lease liability | 6,109 | (373) | 5,736 |
| Total liabilities acquired | $11,997 | $(1,235) | $10,762 |
| Fair value of net identifiable assets acquired | 55,190 | 169 | 55,359 |
| Goodwill | $156,086 | $(688) | $155,398 |
The following table summarizes the intangible assets acquired by class and the weighted-average estimated useful lives:
| February 29, 2024 | Weighted-average estimated useful lives | |
|---|---|---|
| Technology | $14,835 | 7 years |
| Trade names | 1,560 | 5 years |
| Customer relationships | 21,670 | 20 years |
| Total intangible assets | $38,065 |
The fair value of the acquired technology and trade name was determined using the relief from royalty (“RFR”) method. The fair value of the acquired customer relationships was determined using the excess earnings method.
The acquisition was accounted for as a business combination, whereby the excess of the purchase consideration over the fair value of identifiable net assets was allocated to goodwill. The goodwill reflects the potential synergies and expansion of the Company’s offerings across product lines and markets complementary to its existing products and markets. For tax purposes, the goodwill related to the acquisition is deductible.
The post-acquisition net revenues and net loss included in the results of operations for the three months ended March 31, 2025 were $10.7 million and $4.1 million, respectively. The post-acquisition net revenues and net loss included in the results of operations for the three months ended March 31, 2024 were $3.4 million and $1.1 million, respectively.
Pro Forma Financial Data (Unaudited)
The following table presents the pro forma consolidated results of operations of BigBear.ai for the three months ended March 31, 2024 as though the acquisition of Pangiam had been completed as of January 1, 2024.
| Pro forma for the three months ended | |
|---|---|
| Net revenue | $39,432 |
| Net loss | (130,071) |
The amounts included in the pro forma information are based on the historical results and do not necessarily represent what would have occurred if the business combination had taken place as of January 1, 2024, nor do they represent the results that may occur in the future. Accordingly, the pro forma financial information should not be relied upon as being indicative of the results that would have been realized had the acquisition occurred as of the date indicated or that may be achieved in the future.
The Company incurred $1.1 million of transaction expenses attributable to the acquisition of Pangiam during the three months ended March 31, 2024.
Note 6—Fair Value of Financial Instruments
Cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, short-term debt, including the current portion of long-term debt, accrued liabilities and other current liabilities are reflected on the consolidated balance sheets at amounts that approximate fair value because of the short-term nature of these financial assets and liabilities.
Certain warrants that were issued at BigBear.ai’s initial public offering (“IPO Private Warrants”), warrants issued in BigBear.ai’s 2023 and 2024 private placement warrants (“PIPE Warrants”), and warrants issued in BigBear.ai’s 2023, 2024 and 2025 registered direct offering warrants (“RDO Warrants”) are valued using a modified Black-Scholes option pricing model (“OPM”). The conversion options of the 2026 Convertible Notes (“2026 Notes Conversion Option”) and 2029 Convertible Notes (“2029 Notes Conversion Option”) are valued using a binomial lattice convertible bond model and discounted cash flow method, considering the traded price of the 2026 Convertible Notes and 2029 Convertible Notes, respectively, and other unobservable input assumptions. The 2026 Notes Conversion Option, 2029 Notes Conversion Option, and RDO Warrants are considered to be Level 3 fair value measurements. See Note 17—Derivatives for information on the Level 3 inputs used to value the IPO Private Warrants, PIPE Warrants, RDO Warrants, 2026 Notes Conversion Option, and the 2029 Notes Conversion Option.
The table below presents the financial assets and liabilities measured at fair value :
| Balance Sheet Caption · Level 1 · Level 2 · Level 3 · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Recurring fair value measurements: | |||||||||
| 2029 Notes Conversion Option | Derivative liabilities | — | — | 48,821 | 48,821 | ||||
| 2026 Notes Conversion Option | Derivative liabilities | — | — | — | — | ||||
| IPO private warrants | Derivative liabilities | — | — | 70 | 70 | ||||
| 2025 RDO warrants | Derivative liabilities | — | — | 8,558 | 8,558 | ||||
| Total recurring fair value measurements: | — | — | 57,449 | 57,449 | |||||
| Nonrecurring fair value measurement: | |||||||||
| Goodwill | Goodwill | — | — | 119,081 | 119,081 | ||||
| Balance Sheet Caption · Level 1 · Level 2 · Level 3 · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026 Notes Conversion Option | Derivative liabilities | — | — | — | — | ||||
| IPO private warrants | Derivative liabilities | $— | $— | $290 | $290 | ||||
| 2024 PIPE warrants | Derivative liabilities | — | — | 32,760 | 32,760 | ||||
| 2024 RDO warrants | Derivative liabilities | — | — | 21,634 | 21,634 | ||||
| 2029 Notes Conversion Option | Derivative liabilities | — | — | 115,831 | 115,831 | ||||
| Total recurring fair value measurements: | — | — | 170,515 | 170,515 | |||||
| Nonrecurring fair value measurement: | |||||||||
| Goodwill(1) | Goodwill | — | — | 119,081 | 119,081 | ||||
(1) As of March 31, 2024, in accordance with Subtopic 350-20, goodwill with a carrying amount of $204.8 million was written down to its implied fair value of $119.1 million, resulting in an impairment charge of $85.0 million, which was included in earnings during the first quarter. Differences between the implied fair value of $119.1 million and the balance as of December 31, 2024 relate to subsequent measurement period adjustments.
The changes in the fair value of the Level 3 liabilities are as follows:
| IPO private warrants | 2026 Notes Conversion Option | 2024 PIPE warrants | 2024 RDO warrants | 2025 RDO warrants | 2029 Notes Conversion Option | |
|---|---|---|---|---|---|---|
| December 31, 2024 | $290 | $— | $32,760 | $21,634 | $— | $115,831 |
| Additions | — | — | — | — | 18,586 | — |
| Changes in fair value | (220) | — | 42,480 | 17,631 | (10,028) | 29,560 |
| Settlements | — | — | (75,240) | (39,265) | — | (96,570) |
| March 31, 2025 | $70 | $— | $— | $— | $8,558 | $48,821 |
Note 7—Goodwill
First Quarter of Fiscal 2024
During the first quarter of fiscal 2024, we performed a quantitative impairment analysis as a result of a decrease in the Company’s share price during the quarter compared to the share price of the equity issued as consideration for the purchase of Pangiam as described in Note 5. As a result of this testing, we recorded an $85.0 million non-cash goodwill impairment charge during the three months ended March 31, 2024. Our goodwill impairment test reflected an allocation of 50% and 50% between the income and market-based approaches, respectively. Significant inputs into the valuation models included the discount rate, EBITDA growth and estimated future cash flows. We used a discount rate of 30.7%, guideline peer group and their historical and forward-looking revenues in the goodwill impairment test. Subsequent to the impairment, there wasno excess of reporting unit fair value over carrying value.
First Quarter of Fiscal 2025
There wereno goodwill impairment charges recorded during the three months ended March 31, 2025. Accumulated impairment losses to goodwill were$138.5 million as of March 31, 2025.
Note 8—Intangible Assets, net
The intangible asset balances and accumulated amortization are as follows:
| March 31, 2025 | |||||
|---|---|---|---|---|---|
| Grosscarryingamount | Accumulatedamortization | Impact of foreign currency translation | Netcarryingamount | Weightedaverageusefullife in years | |
| Customer relationships | $96,270 | $(17,269) | $— | $79,001 | 20 |
| Technology | 41,035 | (18,130) | — | 22,905 | 7 |
| Software for sale | 15,856 | (1,551) | 145 | 14,450 | 3 |
| Trade name | 1,560 | (316) | — | 1,244 | 5 |
| Total | $154,721 | $(37,266) | $145 | $117,600 | |
| December 31, 2024 | |||||
| Grosscarryingamount | Accumulatedamortization | Impact of foreign currency translation | Netcarryingamount | Weightedaverageusefullife in years | |
| Customer relationships | $96,270 | $(16,064) | $— | $80,206 | 20 |
| Technology | 41,035 | (16,665) | — | 24,370 | 7 |
| Software for sale | 14,459 | (927) | (289) | 13,243 | 3 |
| Trade name | 1,560 | (260) | — | 1,300 | 5 |
| Total | $153,324 | $(33,916) | $(289) | $119,119 | |
Amortization expense of $0.6 million andzero was recognized for the capitalized software development costs during the three months ended March 31, 2025 and March 31, 2024, respectively.
The table below presents all amortization expense related to intangible assets for the following periods:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Amortization expense related to intangible assets | $3,350 | $2,339 |
The table below presents the estimated amortization expense on intangible assets for the next five years and thereafter as of March 31, 2025:
| 2025 | $12,510 |
| 2026 | 14,190 |
| 2027 | 11,790 |
| 2028 | 8,023 |
| 2029 | 7,015 |
| Thereafter | 64,072 |
| Total estimated amortization expense | $117,600 |
Note 9—Prepaid expenses and other current assets
The table below presents details on prepaid expenses and other current assets:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Prepaid insurance | $748 | $1,021 |
| Prepaid expenses | 3,262 | 2,498 |
| Prepaid taxes | 1,537 | 249 |
| Total prepaid expenses and other current assets | $5,547 | $3,768 |
Note 10—Accrued Liabilities
The table below presents details on accrued liabilities:
| March 312025 | December 312024 | |
|---|---|---|
| Payroll accruals(1) | $14,925 | $13,533 |
| Accrued interest | 2,707 | 231 |
| Legal accruals | 650 | 450 |
| Other accrued expenses | 2,445 | 5,283 |
| Impact of foreign currency translation | 7 | (1) |
| Total accrued liabilities | $20,734 | $19,496 |
(1) Inclusive of employer portion of taxes related to the vesting of equity awards and accrued subcontractor labor.
Note 11—Debt
The table below presents the Company’s debt balances:
| March 312025 | December 31, 2024 | |
|---|---|---|
| 2026 Convertible Notes | $17,668 | $17,668 |
| 2029 Convertible Notes | 124,605 | 182,332 |
| D&O Financing Loan | 818 | 818 |
| Total debt | 143,091 | 200,818 |
| Less: unamortized debt issuance discount and costs | 41,685 | 64,596 |
| Total debt, net | 101,406 | 136,222 |
| Less: current portion | 818 | 818 |
| Long-term debt, net | $100,588 | $135,404 |
2026 Convertible Notes
On December 7, 2021, the Company issued $200.0 million of unsecured convertible notes (the“2026 Convertible Notes”) to certain investors. The 2026 Convertible Notes bear interest at a rate of 6.0% per annum, payable semi-annually, and not including any interest payments that are settled with the issuance of shares, were initially convertible into 17,391,304 shares of the Company’s common stock at an initial conversion price of $11.50 (the “Conversion Price”). The Conversion Price is subject to adjustments. On May 29, 2022, pursuant to the 2026 Convertible Notes indenture, the conversion rate applicable to the 2026 Convertible Notes was adjusted to 94.2230 (previously 86.9565) shares of common stock per $1,000 principal amount of 2026 Convertible Notes because the average of the daily volume-weighted average price of the common stock during the preceding 30 trading days was less than $10.00 (the “Conversion Rate Reset”). After giving effect to the Conversion Rate Reset, the Conversion Price is $10.61 and the 2026 Convertible Notes are convertible into 18,844,600 shares, not including any interest payments that are settled with the issuance of shares. The 2026 Convertible Note financing matures on December 15, 2026.
The Company may, at its election and subject to certain conditions, force conversion of the 2026 Convertible Notes after December 15, 2022 and prior to October 7, 2026 if the trading price of the Company’s common stock exceeds 130% of the conversion price for 20 out of the preceding 30 trading days and the 30-day average daily trading volume ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to $3.0 million for the firsttwo years after the initial issuance of the 2026 Convertible Notes and $2.0 million thereafter. In connection with such forced conversion, the conversion rate for the 2026 Convertible Notes will be increased but no Interest Make-Whole Payment (as defined below) will be made in connection with such forced conversion. In the event that a holder of the 2026 Convertible Notes elects to convert the 2026 Convertible Notes (a) prior to December 15, 2024, the Company will be obligated to pay an amount equal totwelve months of interest or (b) on or after December 15, 2024 but prior to December 15, 2025, any accrued and unpaid interest plus any remaining amounts that would be owed up to, but excluding, December 15, 2025 (such interest payments, an “Interest Make-Whole Payments”). The Interest Make-Whole Payments will be payable in cash or shares of the common stock, depending on the average of the daily volume-weighted average price per share of the Company’s common stock for a specified period immediately prior to such conversion, as set forth in the Indenture.
Following certain corporate events that occur prior to the maturity date or if the Company exercises its mandatory conversion right, the conversion rate will be increased in certain circumstances for a holder who elects, or has been forced, to convert its 2026 Convertible Notes in connection with such corporate events or such mandatory conversion.
If a Fundamental Change (as defined in the 2026 Convertible Notes indenture) occurs prior to the maturity date, holders of the 2026 Convertible Notes will have the right to require the Company to repurchase all or any portion of their 2026 Convertible Notes in principal amounts ofone thousand dollars or an integral multiple thereof, at a repurchase price equal to the principal amount of the 2026 Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the repurchase date.
On May 29, 2022, pursuant to the conversion rate adjustment provisions in the indenture, governing the 2026 Convertible Notes, the Conversion Price was adjusted to $10.61 (or 94.2230 shares of common stock perone thousand dollars of principal amount of Convertible Notes). Subsequent to the adjustment, the 2026 Convertible Notes are convertible into 18,844,600 shares, not including any interest payments that are settled with the issuance of shares.
The 2026 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host. Refer to Note 17—Derivatives for more information on the 2026 Notes Conversion Option.
2029 Convertible Notes
On December 19, 2024, the Company entered into privately negotiated exchange agreements (each, an “Exchange Agreement”) with a limited number of holders of the Company’s 2026 Convertible Notes, to exchange the 2026 Convertible Notes for new senior secured convertible notes due 2029 (the “2029 Convertible Notes”, together with the 2026 Convertible Notes, the “Convertible Notes”). The Company exchanged (the “Exchange Transaction”) approximately $182.3 million principal amount of the 2026 Convertible Notes for $182.3 million in aggregate principal amount of the Company’s 2029 Convertible Notes and approximately $0.4 million in cash, with such cash payment representing the accrued and unpaid interest on the 2026 Convertible Notes at the time of the Exchange Transaction. The 2029 Convertible Notes bear interest at a rate of (i)6.0% per annum, if interest is paid in cash and (ii)7.0% per annum, if the Company elects, subject to certain conditions, to pay interest in kind with shares of its common stock. To the extent that the certain liquidity conditions of the Company and its subsidiaries is not satisfied as of the last business day of any calendar month, then with respect to the period applicable to the interest payment date immediately following the month in which such liquidity condition is not satisfied, the interest rate will be (i)9.00% per annum, if interest is paid in cash and (ii)10.00% per annum, if the Company elects, subject to certain conditions, to pay interest in kind with shares of its common stock (it being understood that such increased rate shall apply solely for such six-month period applicable to such interest payment date). Interest is payable semi-annually. The conversion rate is 281.4491 shares of common stock per $1,000 principal amount of 2029 Convertible Notes, which represents an initial conversion price of $3.55 per share of the Company’s common stock. The conversion rate and the conversion price are subject to adjustments. In addition, if certain corporate events that constitute a “Make-Whole Fundamental Change” (as defined in the 2029 Convertible Notes Indenture) occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time.
The exchange was accounted for as an extinguishment of the 2026 Convertible Notes and the 2029 Convertible Notes were recognized at fair value, which approximated the carrying amount of the principal balances exchanged. For the year ended December 31, 2024, the Company recognized a loss on extinguishment of $31.3 million on the consolidated statements of operations related to the unamortized debt issuance costs of the exchanged 2026 Convertible Notes. The Company was in compliance with all covenants through the extinguishment of the exchanged 2026 Convertible Notes.
The 2029 Convertible Notes were issued pursuant to, and are governed by, an indenture (the “2029 Convertible Notes Indenture”), dated as of December 27, 2024. The 2029 Convertible Notes will be fully and unconditionally guaranteed, on a senior, secured basis, by the Company and certain of its existing and future direct and indirect subsidiaries, subject to certain exceptions (the “Guarantors”), and will initially be secured on a first-priority basis by substantially all assets of the Company and such Guarantors, subject to certain exceptions.
Upon completion of the Exchange Transaction, the aggregate principal amount of the 2026 Convertible Notes outstanding was $17.7 million. The Company did not receive any cash proceeds from the issuance of the 2029 Convertible Notes pursuant to the Exchange Transactions.
Holders who convert their 2029 Convertible Notes will also be entitled to an interest make-whole payment of up to 7.5% of the aggregate principal amount of notes converted, subject to reduction as further described in the 2029 Convertible Notes Indenture. Interest make-whole payments are payable in cash or shares of common stock, depending on the average of the daily volume-weighted average price per share of the Company’s common stock for a specified period immediately prior to such conversion. Payment of the interest make-whole in shares will be at a price equal to 95% of such average of the daily volume-weighted average price.
The 2029 Convertible Notes will not be redeemable at the Company’s election before December 27, 2025. The 2029 Convertible Notes will be redeemable, in whole but not in part (subject to certain limitations), for cash at the Company’s option at any time, and from time to time, on or after December 27, 2025 and prior to the close of business on November 16, 2029, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price for a specified period of time and certain other conditions are satisfied. The redemption price will be equal to the principal amount of the 2029 Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.
If a Fundamental Change (as defined in the 2029 Convertible Notes Indenture) occurs, holders of the 2029 Convertible Notes will have the right to require the Company to repurchase their 2029 Convertible Notes for cash in principal amounts of the 2029 Convertible Notes to be repurchased ofone thousand dollars, plus accrued and unpaid interest, if any, to, but excluding, the applicable repurchase date, plus any remaining amounts that would be owed to, but excluding, the maturity date.
The 2026 Convertible Notes and the 2029 Convertible Notes require the Company to meet certain financial and other covenants. As of March 31, 2025, the Company was in compliance with all covenants related to the Convertible Notes.
The 2029 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host. Refer to Note 17—Derivatives for more information on the 2029 Notes Conversion Option.
During the three months ended March 31, 2025, $57.7 million of the 2029 Convertible Notes were voluntarily converted by noteholders following the Exchange Transaction. These conversions have resulted in the issuance of 16.7 million shares of common stock.
The following table presents the carrying amounts and fair values associated with the Convertible Notes as of March 31, 2025. The fair value of the Convertible Notes is considered to be a Level 3 fair value measurement.
| Outstanding balance | Unamortized issuance costs and debt discount | Carrying value | Fair value | |
|---|---|---|---|---|
| 2026 Convertible Notes | $17,668 | $(2,122) | $15,546 | $15,546 |
| 2029 Convertible Notes | 124,605 | (39,563) | 85,042 | 82,950 |
| Total | $142,273 | $(41,685) | $100,588 | $98,496 |
D&O Financing Loan
On December 13, 2024, the Company entered into a $1.1 million loan (the“2025 D&O Financing Loan”) with AFCO Credit Corporation to finance the Company’s directors and officers insurance premium through September 2025. The D&O Financing Loan has an interest rate of 5.99% per annum and a maturity date of September 8, 2025.
On December 20, 2023, the Company entered into a $1.2 million loan (the“2024 D&O Financing Loan”) with US Premium Finance to finance the Company’s directors and officers insurance premium through September 2024. The D&O Financing Loan has an interest rate of 6.99% per annum and a maturity date of September 8, 2024. The 2024 D&O Financing Loan was fully repaid at maturity.
Note 12—Leases
The Company is obligated under operating leases for certain real estate and office equipment assets. The Company’s finance leases are not material. Certain leases contained predetermined fixed escalation of minimum rents at rates ranging from 2.5% to 4.6% per annum and remaining lease terms of up toten years, some of which include renewal options that could extend certain leases to up to an additional five years.
The following table presents supplemental information related to leases:
| March 31,2025 | March 31,2024 | |
|---|---|---|
| Weighted average remaining lease term | 7.93 | 5.20 |
| Weighted average discount rate | 13.58% | 10.64% |
The table below summarizes total lease costs for the following periods:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating lease expense | $677 | $417 |
| Variable lease expense | 95 | — |
| Short-term lease expense | — | — |
| Rent expense | $772 | $417 |
| Three Months Ended March 31, | ||
| 2025 | 2024 | |
| Sublease income recognized (1) | $27 | $23 |
(1)As of March 31, 2025 and March 31, 2024, the Company has subleased three andtwo of its real estate leases, respectively.
The following table presents supplemental cash flow and non-cash information related to leases:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from leases | $605 | $578 |
| Right-of-use assets obtained in exchange for lease obligations - non-cash activity | $— | $— |
As of March 31, 2025, the future annual minimum lease payments for operating leases are as follows:
| 2025 | $1,752 |
| 2026 | 2,275 |
| 2027 | 1,695 |
| 2028 | 1,668 |
| 2029 | 1,713 |
| Thereafter | 7,352 |
| Total future minimum lease payments | $16,455 |
| Less: amounts related to imputed interest | 6,594 |
| Present value of future minimum lease payments | 9,861 |
| Less: current portion of long-term lease liability | 1,091 |
| Long-term lease liability | $8,770 |
Note 13—Income Taxes
The table below presents the effective income tax rate for the following periods:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Effective tax rate | —% | —% |
The Company was taxed as a corporation for federal, state and local income tax purposes for the three periods ended March 31, 2025 and March 31, 2024. The effective tax rate for the periods ended March 31, 2025 and March 31, 2024 differ from the U.S. federal income tax rate of 21.0% primarily due to foreign, state, and local income taxes, permanent differences between book and taxable income, certain discrete items, and the change in valuation allowance.
Note 14—Commitments and Contingencies
Contingencies in the Normal Course of Business
Under certain contracts with the U.S. government and certain governmental entities, contract costs, including indirect costs, are subject to audit by and adjustment through negotiation with governmental representatives. Revenue is recorded in amounts expected to be realized on final settlement of any such audits.
Legal Proceedings
The Company is subject to litigation, claims, investigations and audits arising from time to time in the ordinary course of business. Although legal proceedings are inherently unpredictable, the Company intends to defend itself vigorously with respect to any matters currently pending against it. The outcome of these matters, individually and in the aggregate, is not expected to have a material impact on the Company’s consolidated balance sheets, consolidated statements of operations, or cash flows. As of March 31, 2025, the Company has accrued $0.7 million related to various ongoing legal disputes. The $0.7 million balance as of March 31, 2025, reflects management’s best estimate as of that date and is net of any anticipated amounts recoverable through insurance.
Note 15—Stockholders’ Equity
Common Stock
The table below presents the details of the Company’s authorized common stock as of the following periods:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Common stock: | ||
| Authorized shares of common stock | 500,000,000 | 500,000,000 |
| Common stock par value per share | $0.0001 | $0.0001 |
| Common stock outstanding at the period end | 289,052,369 | 251,554,378 |
Treasury Stock
These shares are measured at cost and presented as treasury stock on the consolidated balance sheets and consolidated statements of stockholders’ equity (deficit).
Dividend Rights
Subject to applicable law and the rights, if any, of the holders of any outstanding series of the Company’s preferred stock or any class or series of stock having a preference over or the right to participate with the Company’s common stock with respect to the payment of dividends, dividends may be declared and paid ratably on the Company’s common stock out of the assets of the Company that are legally available for this purpose at such times and in such amounts as the Company’s Board of Directors (the “Board”) in its discretion shall determine.
Voting Rights
Each outstanding share of the Company’s common stock is entitled toone vote on all matters submitted to a vote of stockholders. Holders of shares of common stock do not have cumulative voting rights.
Conversion or Redemption Rights
The Company’s common stock is neither convertible nor redeemable.
Liquidation Rights
Upon the Company’s liquidation, the holders of the Company’s common stock are entitled to receive pro rata the Company’s assets that are legally available for distribution, after payment of all debts and other liabilities and subject to the prior rights of any holders of the Company’s preferred stock then outstanding.
Preferred Stock
The table below presents the details of the Company’s authorized preferred stock as of the following periods:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Preferred stock: | ||
| Authorized shares of preferred stock | 1,000,000 | 1,000,000 |
| Preferred stock par value per share | $0.0001 | $0.0001 |
| Preferred stock outstanding at the period end | — | — |
The Company’s Board may, without further action by the Company’s stockholders, from time to time, direct the issuance of shares of preferred stock in series and may, at the time of issuance, determine the designations, powers, preferences, privileges and relative participating, optional or special rights as well as the qualifications, limitations or restrictions thereof, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may be greater than the rights of the Company’s common stock. Satisfaction of any dividend preferences of outstanding shares of the Company’s preferred stock would reduce the amount of funds available for the payment of dividends on shares of the Company’s common stock. Upon the affirmative vote of a majority of the total number of directors then in office, the Company’s Board may issue shares of the Company’s preferred stock with voting and conversion rights which could adversely affect the holders of shares of the Company’s common stock.
Note 16—At-the-Market Offering
In April 2023, the Company filed an automatic shelf registration statement on Form S-3 (the “2023 Shelf Registration Statement”) with the SEC registering an indeterminate amount of its common stock, preferred stock, warrants, rights, and units (collectively, “Company securities”). which the SEC declared effective on April 21. 2023. In May 2024, the Company filed a prospectus supplement to the 2023 Shelf Registration Statement which allows the Company to sell, from time to time and at its discretion, Company securities having an aggregate offering price of up to $150 million including shares of common stock that may be sold pursuant to the Company’s controlled equity offering agreement, dated as of May 10, 2024 (the “Controlled Equity Offering Agreement”), with Cantor Fitzgerald & Co.. (“Cantor”), as sales agent, under an “at the market” offering program (the “ATM Program”).
Pursuant to the Controlled Equity Offering Agreement, the Company may offer and sell common stock having an aggregate offering price of up to $150 million from time to time to or through Cantor, subject to the Company’s compliance with applicable laws and the applicable requirements of the Controlled Equity Offering Agreement. The Controlled Equity Offering Agreement stipulates that the Company will pay Cantor a commission equal to up to 3.0% of the gross offering proceeds of any shares of common stock sold to or through Cantor pursuant to the Controlled Equity Offering Agreement. The Company intends to use the net proceeds from sales of common stock issued under the ATM Program for general corporate and working capital purposes. The timing of any sales and the number of shares sold will depend on a variety of factors to be determined and considered by the Company. The Company is not obligated to sell any shares under the Controlled Equity Offering Agreement.
During the three months ended March 31, 2025, the Company sold 1,936,000 shares of common stock under the ATM Program for an aggregate offering price of $6.6 million. Total issuance costs related to the ATM Program as of March 31, 2025 were approximately $0.1 million, resulting in aggregate net proceeds of approximately $6.5 million. As of March 31, 2025, approximately $143.4 million in capacity remained available under the 2023 Shelf Registration Statement.
Note 17—Derivatives
2029 Notes Conversion Option
On December 19, 2024, the Company entered into privately negotiated Exchange Agreements with a limited number of holders of the Company’s 2026 Convertible Notes, to exchange the 2026 Convertible Notes for 2029 Convertible Notes. The 2029 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host.
The table below presents the value of the 2029 Notes Conversion Option under the Black-Scholes OPM using the following assumptions as of the following dates:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Value of 2029 Notes Conversion Option | $48,821 | $115,831 |
| Conversion price | $3.55 | $3.55 |
| Common stock price | $2.86 | $4.45 |
| Expected option term (years) | 4.7 | 5.0 |
| Expected volatility | 50.00% | 37.60% |
| Risk-free rate of return | 3.90% | 4.30% |
| Expected annual dividend yield | —% | —% |
As of March 31, 2025, the 2029 Notes Conversion Option had a fair value of $48.8 million and is presented on theconsolidated balance sheets within derivative liabilities. Again of $30.3 million was recognized during thethree months ended March 31, 2025, and is presented in net increase in fair value of derivatives on theconsolidated statements of operations.
During the three months ended March 31, 2025, $57.7 million of the 2029 Convertible Notes have been voluntarily converted by noteholders following the Exchange Transaction. These conversions resulted in the issuance of approximately 16.7 million shares of common stock in exchange for the retirement of the respective notes. During thethree months ended March 31, 2025, upon conversion of the notes, there was a mark-to-market adjustment to increase the debt conversion option derivative liability, resulting in a loss of $59.9 million, which is included in the net increase in fair value of derivatives and is presented in net increase in fair value of derivatives on the consolidated statements of operations. In conjunction with the conversion, a loss of$2.6 million was recognized for the three months ended March 31, 2025 related to the convertible debt discount and unamortized deferred financing costs, and is presented in loss on extinguishment of debt on the consolidated statements of operations.
As of March 31, 2025, the remaining principal of the 2029 Convertible Notes outstanding was$124.6 million.
2023 RDO Warrants
On June 13, 2023, the Company consummated the closing of a registered direct offering pursuant to an Underwriting Agreement with Cowen and Company, LLC, as representative of the underwriters, for the sale and purchase of an aggregate of 11,848,341 shares of common stock at par value and accompanying common warrants (“RDO warrants”). Each share of common stock is accompanied by a common warrant to purchase three-quarters of a share of common stock at an exercise price of $2.32 per share. The RDO warrants were initially exercisable for up to 8,886,255 shares of common stock and became exercisablesix months after issuance and had afive-year term.
On February 27, 2024, the Company entered into a warrant exercise agreement (the “RDO Warrant Exercise Agreement”) with an existing accredited investor (the “RDO Investor”) to exercise in full the outstanding RDO warrants to purchase up to an aggregate of 8,886,255 shares of the Company’s common stock for gross proceeds of $20.6 million. Upon settlement of the RDO warrants, a loss of $10.1 million was recognized for the three months ended March 31, 2024 and is presented in net increase in fair value of derivatives on the consolidated statements of operations.
2024 RDO Warrants
In consideration for the immediate and full exercise of the RDO warrants, on February 28, 2024, the RDO Investor received a new unregistered common stock purchase warrant to purchase up to an aggregate of 5,800,000 of the Company’s common stock (the “2024 RDO warrants”) in a private placement. The 2024 RDO warrants became exercisablesix months after issuance and had afive-year term, with an exercise price per share equal to$3.78.
The table below presents the value of the 2024 RDO warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 312024 | |
|---|---|
| Value of each 2024 RDO warrant | $3.73 |
| Exercise price | $3.78 |
| Common stock price | $4.45 |
| Expected option term (years) | 4.7 |
| Expected volatility | 120.00% |
| Risk-free rate of return | 4.31% |
| Expected annual dividend yield | —% |
On February 5, 2025, the Company entered into a warrant exercise agreement (the “RDO Warrant Exercise Agreement”) with an existing accredited investor (the “RDO Investor”) to exercise in full the outstanding 2024 RDO warrants to purchase up to an aggregate of 5,800,000 shares of the Company’s common stock for gross proceeds of$21.9 million. Upon settlement of the RDO warrants, a loss of $14.3 million was recognized for the three months ended March 31, 2025 and is presented in net increase in fair value of derivatives on the consolidated statements of operations.
A loss of$5.3 million, which includes transaction costs associated with the issuance of the RDO warrants, was recognized during the three months ended March 31, 2024, and is presented in net increase in fair value of derivatives on theconsolidated statements of operations.
2025 RDO Warrants
In consideration for the immediate and full exercise of the 2024 RDO warrants, on February 5, 2025, the RDO Investor received a new unregistered common stock purchase warrant to purchase up to an aggregate of 3,770,000 of the Company’s common stock (the “2025 RDO warrants”) in a private placement. The 2025 RDO warrants became exercisablesix months after issuance and had afive-year term, with an exercise price per share equal to$9.00.
The table below presents the value of the 2025 RDO warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| March 31,2025 | February 6,2025 | |
|---|---|---|
| Value of each 2025 RDO warrant | $2.27 | $4.93 |
| Exercise price | $9.00 | $9.00 |
| Common stock price | $2.86 | $6.77 |
| Expected option term (years) | 5.4 | 5.5 |
| Expected volatility | 130.00% | 95.00% |
| Risk-free rate of return | 3.94% | 4.25% |
| Expected annual dividend yield | —% | —% |
As of March 31, 2025, the 2025 RDO warrants had a fair value of$8.6 millionand is presented on theconsolidated balance sheets within derivative liabilities. A gain of$10.0 million, which includes transaction costs associated with the issuance of the RDO warrants, was recognized during thethree months ended March 31, 2025 and are presented in net increase in fair value of derivatives on theconsolidated statements of operations.
As of March 31, 2025, there were 3,770,000 2025 RDO warrants issued and outstanding.
2023 PIPE Warrants
On January 19, 2023, the Company consummated the closing of a private placement (the “Private Placement”) by and among the Company and Armistice Capital Master Fund Ltd (the “Purchaser”). At the closing of the Private Placement, the Company issued 13,888,889 shares of the Company’s common stock at par value and warrants to purchase up to an additional 13,888,889 shares of common stock (the “PIPE warrants”). The PIPE warrants became exercisablesix months after issuance and had afive-year term, with an exercise price of $2.39 per share. The PIPE warrants were subject to a 4.99% beneficial ownership limitation.
On March 4, 2024, the Company entered into a warrant exercise agreement (the “PIPE Warrant Exercise Agreement”) with an existing accredited investor (the “PIPE Investor”) to exercise in full the outstanding PIPE warrants to purchase up to an aggregate of 13,888,889 shares of the Company’s common stock for gross proceeds of$33.2 million. Upon settlement of the PIPE warrants, a loss of $32.2 million was recognized as a result of the change in fair value for the three months ended March 31, 2024 and is presented in net increase in fair value of derivatives on the consolidated statements of operations.
2024 PIPE Warrant
In consideration for the immediate and full exercise of the 2023 PIPE warrants, on March 5, 2024, the PIPE Investor received a new unregistered common stock purchase warrant to purchase up to an aggregate of 9,000,000 shares of the Company’s common stock (the “2024 PIPE warrant”) in a private placement. The 2024 PIPE Warrant became exercisablesix months after issuance and had afive-year term, with an exercise price per share equal to$4.75.
The table below presents the value of the 2024 PIPE warrant under the Black-Scholes OPM using the following assumptions as of the following dates:
| December 31,2024 | |
|---|---|
| Value of each 2024 PIPE warrant | $3.64 |
| Exercise price | $4.75 |
| Common stock price | $4.45 |
| Expected option term (years) | 4.7 |
| Expected volatility | 120.00% |
| Risk-free rate of return | 4.32% |
| Expected annual dividend yield | —% |
On February 10, 2025 the Company entered into a warrant exercise agreement (the “PIPE Warrant Exercise Agreement”) with an existing accredited investor (the “PIPE Investor”) to exercise 4,500,000 of the outstanding PIPE warrants to purchase up to an aggregate of 9,000,000 shares of the Company’s common stock for gross proceeds of$21.4 million. Upon settlement of the PIPE warrants, a gain of $0.2 million was recognized as a result of the change in fair value for the three months ended March 31, 2025 and is presented in net increase in fair value of derivatives on the consolidated statements of operations.
On February 11, 2025 the Company entered into an additional PIPE Warrant Exercise Agreement with the same PIPE Investor to exercise the remaining 4,500,000 of the outstanding PIPE warrants to purchase up to an aggregate of 9,000,000 shares of the Company’s common stock for gross proceeds of$21.4 million. Upon settlement of the PIPE warrants, a gain of $0.1 million was recognized as a result of the change in fair value for the three months ended March 31, 2025 and is presented in net increase in fair value of derivatives on the consolidated statements of operations.
2026 Notes Conversion Option (restated)
On December 7, 2021, the Company issued $200.0 million of unsecured convertible notes (the“2026 Convertible Notes”) to certain investors. The 2026 Convertible Notes contain conversion features that meet the definition of a derivative and require separate accounting treatment from the debt host.
The table below presents the value of the 2026 Notes Conversion Option under the Black-Scholes OPM using the following assumptions as of the following dates:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Value of 2026 Notes Conversion Option | $— | $— |
| Conversion price | $10.61 | $10.61 |
| Common stock price | $2.86 | $4.45 |
| Expected option term (years) | 1.7 | 2.0 |
| Expected volatility | 50.00% | 93.30% |
| Risk-free rate of return | 3.90% | 4.25% |
| Expected annual dividend yield | —% | —% |
As of March 31, 2025, the 2026 Notes Conversion Option had a fair value ofzero and is presented on theconsolidated balance sheets within derivative liabilities.
As of March 31, 2025, the remaining principal of the 2026 Convertible Notes outstanding was $17.7 million.
IPO Public Warrants
Each warrant issued in connection with the Company’s initial public offering (the “IPO public warrants”) entitles the registered holder to purchaseone share of common stock at a price of $11.50 per share, subject to adjustment. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. The warrants will expire on December 7, 2026, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company may call the IPO public warrants for redemption as follows: (1) in whole and not in part; (2) at a price of $0.01 per warrant; (3) upon a minimum of 30 days’ prior written notice of redemption; (4) if there is an effective registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus available throughout the 30-day notice period; and (5) only if the last reported closing price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
If the Company calls the IPO public warrants for redemption, management will have the option to require all holders that wish to exercise the Company IPO public warrants to do so on a “cashless basis.”
The exercise price and number of shares of common stock issuable upon exercise of the IPO public warrants may be adjusted in certain circumstances including stock dividends, stock splits, extraordinary dividends, consolidation, combination, reverse stock split or reclassification of shares of the Company’s common stock or other similar event. In no event will the Company be required to net cash settle the warrant shares.
The table below presents the Company’s IPO public warrants issued and outstanding as of the following periods:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| IPO public warrants issued | 12,251,606 | 12,168,378 |
| IPO public warrants outstanding | 12,251,606 | 12,168,378 |
IPO Private Warrants
The terms and provisions of the IPO public warrants above also apply to the private warrants issued by the Company (“IPO private warrants”). If the IPO private warrants are held by holders other than GigAcquisitions4, LLC (“Sponsor”), Oppenheimer & Co. Inc. and Nomura Securities International, Inc. (together, the“Underwriters”), or any respective permitted transferees, the IPO private warrants will be redeemable by the Company and exercisable by the holders on the same basis as the IPO public warrants. The Sponsor, the Underwriters and any respective permitted transferees have the option to exercise the IPO private warrants on a cashless basis.
The table below presents the value of the IPO private warrants under the Black-Scholes OPM using the following assumptions as of the following dates:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Fair value of each IPO private warrant | $0.94 | $1.84 |
| Exercise price | $11.50 | $11.50 |
| Common stock price | $2.86 | $1.46 |
| Expected option term (in years) | 1.7 | 2.2 |
| Expected volatility | 130.00% | 93.30% |
| Risk-free rate of return | 3.90% | 3.60% |
| Expected annual dividend yield | —% | —% |
As of March 31, 2025 and December 31, 2024, the IPO private warrants have a fair value of $0.1 million and $0.3 million and are presented on the consolidated balance sheets within derivative liabilities. The following was recognized as a result of the change in fair value for the three and the three months ended March 31, 2025 and March 31, 2024 and is presented in net increase in fair value of derivatives on the consolidated statements of operations:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Gain on change in fair value of IPO private warrants | $220 | $— |
The table below presents the Company’s IPO private warrants issued and outstanding as of the following periods:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| IPO private warrants issued | 366,533 | 366,533 |
| IPO private warrants outstanding | 74,166 | 157,394 |
Note 18—Equity-Based Compensation
Class B Unit Incentive Plan
In February 2021, the Company’s parent, BBAI Ultimate Holdings, LLC (“Parent”) adopted a compensatory benefit plan (the“Class B Unit Incentive Plan”) to provide incentives to directors, managers, officers, employees, consultants, advisors and/or other service providers of the Company’s Parent or its Subsidiaries in the form of the Parent’s Class B Units (“Incentive Units”). Incentive Units have a participation threshold of $1.00 and are divided into three tranches (“Tranche I,” “Tranche II,” and “Tranche III”). Tranche I Incentive Units are subject to performance-based, service-based and market-based conditions. The grant date fair value for the Incentive Units was $5.19 per unit.
The assumptions used in determining the fair value of the Incentive Units at the grant date are as follows:
| February 16,2021 | |
|---|---|
| Volatility | 57.0% |
| Risk-free interest rate | 0.1% |
| Expected time to exit (in years) | 1.6 |
On July 29, 2021, the Company’s Parent amended the Class B Unit Incentive Plan so that the Tranche I and the Tranche III Incentive Units immediately became fully vested, subject to continued employment or provision of services, upon the closing of the transaction stipulated in the Agreement and Plan of Merger (the“Gig Business Combination Agreement”) dated June 4, 2021. The Company’s Parent also amended the Class B Unit Incentive Plan so that the Tranche II Incentive Units will vest on any liquidation event, as defined in the Class B Unit Incentive Plan, rather than only upon the occurrence of an Exit Sale, subject to the market-based condition stipulated in the Class B Unit Incentive Plan prior to its amendment.
Equity-based compensation for awards with performance conditions is based on the probable outcome of the related performance condition. The performance conditions required to vest per the amended Incentive Plan remain improbable until they occur due to the unpredictability of the events required to meet the vesting conditions. As such events are not considered probable until they occur, recognition of equity-based compensation for the Incentive Units is deferred until the vesting conditions are met. Once the event occurs, unrecognized compensation cost associated with the performance-vesting Incentive Units (based on their modification date fair value) will be recognized based on the portion of the requisite service period that has been rendered.
The modification date fair value of the Incentive Units was $9.06 per unit. The assumptions used in determining the fair value of the Incentive Units at the modification date are as follows:
| July 29,2021 | |
|---|---|
| Volatility | 46.0% |
| Risk-free interest rate | 0.2% |
| Expected time to exit (in years) | 1.2 |
The volatility used in the determination of the fair value of the Incentive Units was based on analysis of the historical volatility of guideline public companies and factors specific to the Company.
On December 7, 2021, the previously announced Gig Business Combination was consummated. As a result, the Tranche I and Tranche III Incentive Units immediately became fully vested and the performance condition for the Tranche II Incentive Units was met. The fair value determined at the date of the amendment of the Class B Unit Incentive Plan was immediately recognized as compensation expense on the vesting date for Tranches I and III. Compensation expense for the Tranche II Incentive Units is recognized over the derived service period of 30 months from the modification date. The remaining compensation expense for the Tranche II Incentive Units will be recognized over the remaining service period of approximately 25 months from the date of the amendment. During the year ended December 31, 2022, the Company’s Parent modified the vesting conditions forfour former employees. Under the original terms of the grant agreements, Incentive Units are forfeited upon separation. Due to the amended agreement, the Incentive Units held by the former employees are no longer contingent upon service and are considered vested as of the separation dates. The former employees will not receive the awards until the market condition is achieved. The result of the amended agreement is an accounting modification that resulted in 100% of the compensation expense being recognized for the former employees based on the modification date fair value. The incremental compensation cost recognized as a result of the modification was $1.5 million during the year ended December 31, 2022.
As of March 31, 2025, there wasno unrecognized compensation cost related to Tranche II Incentive Units and 1,155,000 units remain unvested.
Stock Options
On December 7, 2021, the Company adopted the BigBear.ai Holdings, Inc. 2021 Long-Term Incentive Plan (the“Plan”). The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by providing eligible employees, prospective employees, consultants and non-employee directors of the Company the opportunity to receive stock- and cash-based incentive awards.
During the three months ended March 31, 2025, pursuant to the Plan, the Company’s Board of Directors granted certain grantees Stock Options to purchase shares of the Company’s common stock at a weighted-average exercise price of $3.39. The Stock Options vest over four years with 25% vesting on the one year anniversary of the grant date and 6.25% vesting on the last day of each calendar quarter thereafter until the grant is fully vested. Vesting is contingent upon continued employment or service to the Company and is accelerated in the event of death, disability, or a change in control, subject to certain conditions; both the vested and unvested portion of a Grantee’s Stock Options will be immediately forfeited and cancelled if the Grantee ceases employment or service to the Company. The Stock Options expire on the 10 th anniversary of the grant date.
The table below presents the fair value of Stock Options that were granted during the three months ended March 31, 2025 using the Black-Scholes OPM and the following assumptions:
| Number of Stock Options granted | 671,141 |
|---|---|
| Price of common stock on the grant date | $3.39 |
| Expected option term (in years) | 6.1 |
| Expected volatility(1) | 120% |
| Risk-free rate of return | 4.45% |
| Expected annual dividend yield | —% |
| Fair value of the Stock Options on the grant date | $2.98 |
(1)Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.
The table below presents the activity of outstanding stock options:
| Stock Options Outstanding | Weighted-Average Exercise Price Per Share | Weighted-Average Remaining Contractual Life (in years) | Aggregate Intrinsic Value | |
|---|---|---|---|---|
| Outstanding as of December 31, 2024 | 3,930,602 | $2.12 | 8.01 | $10,138 |
| Granted | 671,141 | 3.18 | ||
| Vested | — | — | ||
| Exercised | (983,434) | 1.41 | ||
| Forfeited | (699,815) | 1.40 | ||
| Expired | — | — | ||
| Outstanding as of March 31, 2025 | 2,918,494 | $2.78 | 8.24 | $1,956 |
| Vested and exercisable as of March 31, 2025 | 1,762,322 | $2.60 | 7.71 | $1,612 |
The stock options had $2.0 million intrinsic value as of March 31, 2025. The Company recognizes equity-based compensation expense for the stock options equal to the fair value of the awards on a straight-line basis over the service based vesting period. As of March 31, 2025, there was approximately $2.9 million of unrecognized compensation costs related to the stock options, which is expected to be recognized over the remaining weighted average period of 3 years.
Restricted Stock Units
During the three months ended March 31, 2025, pursuant to the Plan, the Company’s Board communicated the key terms and committed to grant Restricted Stock Units (“RSUs”) to certain employees and certain nonemployee directors and consultants. The Company granted 680,795 RSUs to employees and 84,068 RSUs to nonemployee directors during the three months ended March 31, 2025. RSUs granted to employees generally vest over four years, with 25% vesting on the one year anniversary of the grant date and then 6.25% per each quarter thereafter on the two, three and four year anniversary of the grant date. RSUs granted to nonemployee directors vest 25% each quarter following the grant date or 100% upon the first anniversary of the grant date. Vesting of RSUs is accelerated in the event of death, disability, or a change in control, subject to certain conditions.
The table below presents the activity in the RSUs:
| RSUsOutstanding | Weighted-Average Grant Date Fair Value Per Share | |
|---|---|---|
| Unvested as of December 31, 2024 | 13,870,402 | $1.94 |
| Granted | 764,863 | 3.59 |
| Vested | (792,011) | 2.57 |
| Forfeited | (1,806,621) | 1.60 |
| Unvested as of March 31, 2025 | 12,036,633 | $2.05 |
As of March 31, 2025, there was approximately $20.7 million of unrecognized compensation costs related to the RSUs, which is expected to be recognized over the remaining weighted average period of 1.46 years.
Performance Stock Units
Pursuant to the Plan, the Company’s Board communicated the key terms and granted Performance Stock Units (“PSUs”) to certain employees. The Company grants PSUs to certain employees with performance measures specific to the role of that employee or as a retention incentive (“Discretionary PSUs”). During the three months ended March 31, 2025, the Company granted zero Discretionary PSUs. The Company granted 991,548 Short-term Incentive PSUs (“STI PSUs”) to employees, which contain performance measures based on a combination of Company’s financial performance as well as the individual’s personal performance. The number of STI PSUs that will vest is based on the achievement of the performance criteria during each respective annual measurement period, provided that the employees remain in continuous service on each vesting date. Vesting will not occur unless a minimum performance criteria threshold is achieved.
During the three months ended March 31, 2025, the Board approved a grant of 991,548 PSUs to certain employees related to STIP PSUs for the 2024 plan year. These STIP PSUs were granted in lieu of cash payouts and were fully vested upon award.
The table below presents the activity in the PSUs:
| PSUsOutstanding | Weighted-Average Grant Date Fair Value Per Share | |
|---|---|---|
| Unvested as of December 31, 2024 | 2,933,616 | $2.88 |
| Granted | 991,548 | 3.68 |
| Vested | (2,595,060) | 2.93 |
| Forfeited | (10,417) | 3.46 |
| Unvested as of March 31, 2025 | 1,319,687 | $3.38 |
As of March 31, 2025, there was approximately $2.1 million of unrecognized compensation costs related to the Retention PSUs and STI PSUs, which is expected to be recognized over the remaining average period of 0.88 years.
Employee Share Purchase Plan (“ESPP”)
Concurrently with the adoption of the Plan, the Company’s Board adopted the 2021 Employee Stock Purchase Plan (the “ESPP”), which authorizes the grant of rights to purchase common stock of the Company to employees, officers and directors (if they are otherwise employees) of the Company. As of March 31, 2025, the Company reserved an aggregate of 5,832,221 common shares (subject to annual increases on January 1 of each year and ending in 2031) of the Company’s common stock for grants under the ESPP. During the three months ended March 31, 2025, zero shares were sold under the ESPP. As of March 31, 2025, the Company has withheld employee contributions of $0.8 million for future ESPP purchases, which are presented on theconsolidated balance sheets within other current liabilities.
Equity-based compensation expense related to purchase rights issued under the ESPP is based on the Black-Scholes OPM fair value of the estimated number of awards as of the beginning of the offering period. Equity-based compensation expense is recognized using the straight-line method over the offering period.
The table below presents the assumptions used to estimate the grant date fair value of the purchase rights under the ESPP:
| December 31, 2024 | |
|---|---|
| Price of common stock on the grant date | $1.50 to $2.20 |
| Expected term (in years) | 0.50 |
| Expected volatility(1) | 122.9% to 101.0% |
| Risk-free rate of return | 5.3% to 4.3% |
| Expected annual dividend yield | —% |
| Fair value of the award on the grant date | $0.74 to $2.15 |
(1)Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.
As of March 31, 2025, there was approximately $0.2 million of unrecognized compensation costs related to the ESPP, which is expected to be recognized over the remaining weighted average period of 0.16 years.
Equity-based Compensation Expense
The table below presents the total equity-based compensation expense recognized for Class B Units, Stock Options, RSUs, PSUs, and ESPP in selling, general and administrative expense, cost of revenues, and research and development for the following periods:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Equity-based compensation expense in selling, general and administrative | $4,087 | $2,171 |
| Equity-based compensation expense in cost of revenues | 2,536 | 2,653 |
| Equity-based compensation expense in research and development | 777 | 333 |
| Total equity-based compensation expense | $7,400 | $5,157 |
Note 19—Net Loss Per Share
The numerators and denominators of the basic and diluted netloss per share are computed as follows (in thousands, except per share, unit and per unit data):
| Three Months Ended March 31, | ||
|---|---|---|
| Basic and diluted net loss per share | 2025 | 2024 |
| Numerator: | ||
| Net loss | $(61,986) | $(127,792) |
| Denominator: | ||
| Weighted average shares outstanding—basic | 252,341,401 | 187,279,204 |
| Weighted average shares outstanding—diluted | 252,341,401 | 187,279,204 |
| Basic net loss per share | $(0.25) | $(0.68) |
| Diluted net loss per share | $(0.25) | $(0.68) |
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Stock options | 2,918,494 | 4,550,753 |
| Private warrants | 74,166 | 174,894 |
| Public warrants | 12,251,606 | 12,150,878 |
| 2023 PIPE warrants | — | — |
| 2024 PIPE warrants | — | 9,000,000 |
| 2023 RDO warrants | — | — |
| 2024 RDO warrants | — | 5,800,000 |
| 2025 RDO warrants | 3,770,000 | — |
| 2026 Convertible notes | 1,664,939 | 18,844,600 |
| 2029 Convertible notes | 35,100,000 | — |
| PSUs | 2,752,613 | 1,841,002 |
| RSUs | 12,191,127 | 338,151 |
| ESPP | 575,303 | 1,128,675 |
| Total | 71,298,248 | 53,828,953 |
Note 20—Revenues
Substantially all revenues were generated within the United States of America.
The table below presents total revenues by contract type for the following periods:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Time and materials | $23,232 | $17,960 |
| Firm fixed price | 7,102 | 10,046 |
| Cost-reimbursable | 4,423 | 5,115 |
| Total revenues | $34,757 | $33,121 |
The majority of the Company’s revenue is recognized over time. Revenue derived from contracts that recognize revenue at a point in time was insignificant for all periods presented.
The table below summarizes the activity in the allowance for expected credit losses:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Beginning balance | $127 | $230 |
| Additions | — | — |
| Write-offs | — | (59) |
| Recoveries | — | — |
| Ending balance | $127 | $171 |
Concentration of Risk
Revenue earned from customers contributing in excess of 10% of total revenues are presented in the tables below for the following periods:
| Three Months Ended March 31, 2025 | ||
|---|---|---|
| Total | Percent of totalrevenues | |
| Customer A | $6,537 | 19% |
| Customer B(1) | 4,890 | 14% |
| Customer C | 4,341 | 12% |
| Customer D(1) | 3,563 | 10% |
| Customer E(1) | — | —% |
| All others | 15,426 | 45% |
| Total revenues | $34,757 | 100% |
| Three Months Ended March 31, 2024 | ||
|---|---|---|
| Total | Percent of totalrevenues | |
| Customer A | $6,350 | 19% |
| Customer B(1) | — | —% |
| Customer C | 4,594 | 14% |
| Customer D(1) | — | —% |
| Customer E(1) | 7,113 | 21% |
| All others | 15,064 | 46% |
| Total revenues | $33,121 | 100% |
(1) Customers that contributed in excess of 10% of consolidated revenues in any period presented have been included in all periods presented for comparability.
Contract Balances
The table below presents the contract assets and contract liabilities included on the consolidated balance sheets for the following periods:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Contract assets | $512 | $895 |
| Contract liabilities | $3,017 | $2,541 |
The change in contract assets between December 31, 2024 and March 31, 2025 was primarily driven by invoices being issued for services previously rendered. The change in contract liability balances between December 31, 2024 and March 31, 2025 was primarily driven by upfront payments for services yet to be rendered to customers. Revenue recognized in the three months ended March 31, 2025 that was included in thecontract liability balance as of December 31, 2024 was$0.9 million.
When the Company’s estimate of total costs to be incurred to satisfy a performance obligation exceeds the expected revenue, the Company recognizes the loss immediately. When the Company determines that a change in estimate has an impact on the associated profit of a performance obligation, the Company records the cumulative positive or negative adjustmentin the consolidated statements of operations. Changes in estimates and assumptions related to the status of certain long-term contracts may have a material effect on the Company’s operating results.
The following table summarizes the impact of the net estimates at completion (“EAC”) adjustments on the Company’s operating results:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Net EAC Adjustments, before income taxes | $410 | $(240) |
| Net EAC Adjustments, net of income taxes | $324 | $(189) |
| Net EAC Adjustments, net of income taxes, per diluted share | $— | $— |
Remaining Performance Obligations
The Company includes in its computation of remaining performance obligations customer orders for which it has accepted signed sales orders and generally includes the funded and unfunded components of contracts that have been awarded. As of March 31, 2025, the aggregate amount of the transaction price allocated to remai ning performance obligations was $90.2 million. The Company expects to recognize approximately 98% of its remaining performance obligations as revenue within the next 12 months and the balance thereafter.
Note 21—Segments
The Company has determined that it operates in a single operating and reportable segment, as the Chief Operating Decision Maker (“CODM”) reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The Company’s CODM is its Chief Executive Officer.
Consolidated net loss is the primary measure of segment profitability used by the CODM to assess performance and to allocate resources to the segment. The Company’s significant segment expenses, which reflects segment-level information that is regularly provided to the CODM, consist of adjusted cost of revenues, adjusted selling and marketing, adjusted general and administrative, and adjusted research and development. Other material segment expenses and other segment items are presented to reconcile significant segment expenses to consolidated net loss.
The tables below present the Company’s operating segment results of operations for the following periods:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenues | $34,757 | $33,121 |
| Less significant segment expenses: | ||
| Adjusted cost of revenues | 24,209(a) | 23,482(f) |
| Adjusted selling and marketing | 1,689(b) | 926(b) |
| Adjusted general and administrative | 12,179(c) | 11,961(g) |
| Adjusted research and development | 3,389(d) | 812(d) |
| Goodwill impairment | — | 85,000 |
| Equity-based compensation expense | 7,400 | 5,157 |
| Net increase in fair value of derivatives | 33,336 | 23,807 |
| Interest income | (556) | (447) |
| Interest expense | 5,116 | 6,385 |
| Depreciation and amortization | 3,470 | 2,439 |
| Loss on extinguishment of debt | 2,577 | — |
| Other segment items | 3,934(e) | 1,391(h) |
| Consolidated net loss | $(61,986) | $(127,792) |
(a) Adjusted cost of revenues consists of cost of revenues adjusted to remove amortization expense and equity-based compensation expense.
(b) Adjusted selling and marketing consists of selling and marking costs adjusted to remove equity-based compensation expense.
(c) Adjusted general and administrative consists of general and administrative costs adjusted to remove depreciation and amortization costs, equity-based compensation expense, employer payroll taxes related to equity-based compensation, non-recurring strategic initiatives costs, non-recurring integration costs, and non-recurring litigation expenses.
(d) Adjusted research and development expenses consists of research and development costs adjusted to remove equity-based compensation expense.
(e) Other segment items included in consolidated net loss includes employer payroll taxes related to equity-based compensation, non-recurring strategic initiatives costs, non-recurring integration costs, non-recurring litigation costs, restructuring charges, income tax expense, and other income and expense.
(f) Adjusted cost of revenues consists of cost of revenues adjusted to remove equity-based compensation expense.
(g) Adjusted general and administrative consists of general and administrative costs adjusted to remove depreciation and amortization costs, equity-based compensation expense, employer payroll taxes related to equity-based compensation, non-recurring integration, and non-recurring litigation expenses.
(h)Other segment items included in consolidated net loss includes employer payroll taxes related to equity-based compensation, non-recurring strategic initiatives costs, non-recurring litigation costs, non-recurring integration costs, restructuring charges, transaction expenses, income tax expense, and other income and expense.
Note 22—Subsequent Events
On April 11, 2025, the Company reconvened a special meeting of stockholders (the “Special Meeting”), which was initially convened on March 31, 2025 and adjourned to April 11, 2025 due to a lack of quorum based on the February 28, 2025 record date. At the reconvened Special Meeting, a quorum was present and the stockholders approved the issuance of the Company’s common stock upon the conversion of its 2029 Convertible Notes and shares of the Company’s common stock in lieu of cash interest payments on the 2029 Convertible Notes.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.